Content relating to Edwards Lifesciences devices is intended for healthcare professionals.
RESILIA tissue valve portfolio
Explore the Edwards RESILIA tissue aortic and mitral products below.
INSPIRIS RESILIA aortic valve
Right for today.
Ready for tomorrow.
MITRIS RESILIA mitral valve
Designed to handle the pressure of the mitral position.
*No clinical data are available that evaluate the long-term impact of RESILIA tissue in patients.
Spotlight on RESILIA tissue
Tissue with a difference
A key challenge with pericardial tissue is structural valve deterioration (SVD), much of which is due to calcium buildup. RESILIA tissue is transformed to resist calcification differently. It offers enhanced anti-calcification technology that will potentially allow the valve to last longer than conventional bioprosthetic valves.*
Visit the RESILIA tissue pre-clinical and clinical data Inspiring Results page to learn about how the tissue is performing.
*RESILIA tissue tested against tissue from commercially-available bovine pericardial valves from Edwards in a juvenile sheet model. Flameng, et al. J Thorac Cardiovasc Surg 2015;149;340-5.
**No clinical data are available that evaluate the long-term impact of RESILIA tissue in patients.
